Art

J-GLOBAL ID：201802257284692084   Reference number：18A0143444

Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib

IL-10受容体βの多型は,サリドマイドまたはボルテゾミブで治療した多発性骨髄腫患者の予後に影響する【Powered by NICT】

Author (12)： Kasamatsu Tetsuhiro (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan) ,  Saitoh Takayuki (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan) ,  Ino Rumi (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan) ,  Gotoh Nanami (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan) ,  Mitsui Takeki (Department of Medicine and Clinical Science, Gunma University, Maebashi, Gunma, Japan) ,  Shimizu Hiroaki (Department of Medicine and Clinical Science, Gunma University, Maebashi, Gunma, Japan) ,  Matsumoto Morio (National Hospital Organization, Nishigunma National Hospital, Shibukawa, Gunma, Japan) ,  Sawamura Morio (National Hospital Organization, Nishigunma National Hospital, Shibukawa, Gunma, Japan) ,  Yokohama Akihiko (Blood Transfusion Service, Gunma University Hospital, Maebashi, Gunma, Japan) ,  Handa Hiroshi (Department of Medicine and Clinical Science, Gunma University, Maebashi, Gunma, Japan) ,  Tsukamoto Norifumi (Oncology Center, Gunma University Hospital, Maebashi, Gunma, Japan) ,  Murakami Hirokazu (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan)
Material： Hematological Oncology  (Haematol Oncol)
Volume： 35  Issue： 4  Page： 711-718  Publication year： 2017 
JST Material Number： D0357E  ISSN： 0278-0232  CODEN： HAONDL  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Interleukin-10 (IL-10) and IL-...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0143444&from=J-GLOBAL&jstjournalNo=D0357E") }}

Thesaurus term： polymerase chain reaction ,  Genotype ,  survival ratio ,  single nucleotide polymorphism ,  pathogenesis ,  *Multiple Myeloma ,  promoter (genetics) ,  *receptor ,  gene frequency ,  *patient ,  *interleukin 10 ,  sensitivity ,  genomic DNA ,  Heredity ,  population genetics ,  aromatic carboxylic acid ,  immunotherapeutic drug ,  acid imide ,  polynuclear aromatic compound ,  dicarboxylic acid
Semi thesaurus term： RFLP , 【Automatic Indexing@JST】

Author keywords (5)： bortezomib ,  interleukin-10 receptor ,  multiple myeloma ,  polymorphism ,  thalidomide

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Thalidomide

Terms in the title (8)： IL-10 ,  受容体 ,  多型 ,  サリドマイド ,  ボルテゾミブ ,  治療 ,  多発性骨髄腫 ,  患者の予後